Physician profile
Thomas C Teather
NPI 1265574917
$383.89
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.03 · 2020: $98.17 · 2021: $181 · 2022: $53.12.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $62.93 | 2020 | |
| Novartis Pharmaceuticals Corporation | $57.99 | 2020-2022 | |
| Aerie Pharmaceuticals, INC. | $43.43 | 2019-2021 | |
| Eyevance Pharmaceuticals LLC | $34.61 | 2019-2020 | |
| Horizon Therapeutics Plc | $30.82 | 2021 | |
| Kala Pharmaceuticals, INC. | $23.58 | 2021 | |
| Alcon Vision LLC | $23.46 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $21.03 | 2021 | |
| Oyster Point Pharma, INC. | $20.73 | 2022 | |
| Shire North American Group INC | $18.27 | 2019 | |
| Biotissue Holdings INC. | $16.75 | 2021 | |
| Mallinckrodt Hospital Products INC. | $15.51 | 2022 | |
| Allergan, INC. | $14.78 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Teather listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.